DOCSLIB.ORG

Papillomaviruses Likelihood of Secondary Transmission

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Papillomaviruses Likelihood of Secondary Transmission APPENDIX 2 Papillomaviruses Likelihood of Secondary Transmission: • High by direct contact, especially in older children Disease Agent: and young adults • Human papillomavirus (HPV) • High by sexual contact Disease Agent Characteristics: At-Risk Populations: • Family: Papillomaviridae; Genus: Alpha-Papilloma- • Older children and young adults (nongenital skin virus warts) • Virion morphology and size: Nonenveloped, icosahe- • Persons who are sexually active with multiple dral nucleocapsid symmetry, spherical particles, partners 52-55 nm in diameter • Adult patients with Fanconi anemia • Nucleic acid: Circular, double-stranded DNA, 7.9 kb • HPV-infected persons exposed to sun or UV light in length with unidirectional transcription • Increased susceptibility in immune suppressed • Physicochemical properties: Sparse information; pre- patients sumably susceptible to 0.3% povidone-iodine, to polysulfated and polysulfanated compounds, and to Vector and Reservoir Involved: dilute solutions of sodium dodecyl sulfate; ether- resistant, acid-stable, and heat-stable • None Disease Name: Blood Phase: • Nongenital skin warts • One study found HPV DNA in PBMCs, serum, and • Epidermodysplasia verruciformis plasma of patients with cervical and neck cancers and • Anogenital warts (condylomas) in 3 of 19 (15%) PBMCs from healthy blood donors. • Nonmelanoma skin cancer • Cervical cancer Survival/Persistence in Blood Products: • Anogenital cancer, penile cancer • Unknown • Papillomas of respiratory tract, larynx, mouth, or con- junctiva that includes oral and laryngeal cancers Transmission by Blood Transfusion: Priority Level: • In a recent study of 57 HIV-infected children, seven of • Scientific/Epidemiologic evidence regarding blood eight who were HPV DNA positive had a history of safety: Theoretical blood and/or plasma derivative transfusion as the • Public perception and/or regulatory concern regard- cause of their HIV infection. ing blood safety: Absent • Bovine papillomavirus type 2 has been transmitted • Public concern regarding disease agent: through blood via intramuscular inoculations. Low/Moderate Cases/Frequency in Population: Background: • Over 100 HPV types have been identified, 13 of which • Stable in population have been strongly or moderately associated with cer- • Narrow host range restricted to sites with stratified vical cancer. squamous epithelia that are cornified (skin) or non- • 2-3% of women undergoing routine Pap smear have cornified (genital and nongenital mucosa) abnormal cytology, the majority of which is associ- • High risk types found most frequently in association ated with HPV. with cervical cancer • The peak prevalence is seen in women 15-25 years of • New disease associations have been recognized over age, which may be 25-40%, and then declines with time. increasing age. Common Human Exposure Routes: Incubation Period: • Infection of basal keratinocytes primarily through • Limited information because exposures are generally wounds or skin abrasions multiple and onset is insidious • Contact with infected tissue or contaminated objects • Autoinoculation from site to site Likelihood of Clinical Disease: • Sexual intercourse • Delivery through infected birth canal • Varies with the particular strain 136S TRANSFUSION Volume 49, August 2009 Supplement APPENDIX 2 Primary Disease Symptoms: • Not indicated because transfusion transmission has not been demonstrated. • The typical skin lesion, the wart, is easily recognized, • No sensitive or specific question is feasible. particularly when in its most common location, the hands or feet (plantar warts). Most spontaneously Laboratory Test(s) Available: regress. • No FDA-licensed blood donor screening test exists. • Anogenital warts are also easy to recognize but may • Tissue diagnosis is usually by nucleic acid hybridiza- be internal and only observed following an appropri- tion or extraction of DNA followed by NAT. Southern ate examination. These can be recurrent, sometimes blots of extracted DNA are the gold standard and painful, and difficult to treat but may spontaneously allow for subtyping. remit. • Electron microscopy for viral particles or immuno- • Cervical intraepithelial neoplasia and cervical cancer logic detection of viral capsid antigens has low sensi- are often asymptomatic and only detected on routine tivity. Detection in PBMCs is generally performed by examination, primarily after cervical cytology has PCR or nested PCR. been assessed. Symptoms, such as bleeding and pain, appear as the cancer expands and disseminates. Currently Recommended Donor Deferral Period: • Other symptoms depend on location of the papilloma • No FDA Guidance or AABB Standard exists. and can include vocal disturbances from laryngeal • There is no indication for deferral of individuals with papillomatosis, pulmonary dysfunction from respira- known HPV infection unless presenting with a defer- tory tract involvement, and local discomfort from oral rable malignancy. lesions. Impact on Blood Availability: Severity of Clinical Disease: • Agent-specific screening question(s): Not applicable • Generally benign, except that it can lead to cervical • Laboratory test(s) available: Not applicable and anal cancers (most common cause of these malig- Impact on Blood Safety: nancies), and benign papillomatosis can be debilitat- ing because of location (e.g., laryngeal disease). • Agent-specific screening question(s): Not applicable • Laboratory test(s) available: Not applicable Mortality: Leukoreduction Efficacy: • Highly dependent on genotype and whether cancer • Unknown, but if virus is carried in peripheral blood, it ensues. Mortality is low, even in cancer patients if is probably within PBMCs, and thus leukoreduction early methods of detection are employed. would be expected to have some impact. Chronic Carriage: Pathogen Reduction Efficacy for Plasma Derivatives: • Chronic infection is typical although there is late • This is a nonenveloped virus and thus would not be spontaneous clearance. However, chronic viremia is affected by solvent-detergent treatment. unlikely. HPV may be carried in WBCs that intermit- • No data from model viruses tently seed the blood stream. Other Preventive Measures: Treatment Available/Efficacious: • Pathogen reduction strategies based on inactivation of DNA should be effective. • There are a variety of treatments for disease caused by • A quadrivalent human papilloma vaccine (Gardasil, HPV, ranging from simple intralesional or parenteral MSD) is available against HPV types 6, 11, 16, and 18, interferon or destructive therapy for genital warts, to which cause 70% of cervical cancer cases and 90% of surgery, laser excision repair, cryotherapy, or chemo- genital warts cases. therapy for high-grade dysplasia for cervical infection or cervical cancer. Successful therapy is associated Suggested Reading: with the disappearance of HPV DNA. 1. Antonsson A, Karanfilovska S, Lindqvist PG, Hansson • Therapeutic vaccines have had only limited success. BG. General acquisition of human papillomavirus Agent-Specific Screening Question(s): infections of skin occurs in early infancy. J Clin Micro- biol 2003;41:2509-14. • No specific question is in use; some donors with HPV- 2. Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, associated cancer may be temporarily excluded by Zheng ZM. Could human papillomaviruses be spread current donor history questions. through blood? J Clin Microbiol 2005;43:5428-34. Volume 49, August 2009 Supplement TRANSFUSION 137S APPENDIX 2 3. de Villiers E, Fauquet C, Broker TR, Bernard HU, zur 5. Stocco dos Santos RC, Lindsey CJ, Ferraz OP,Pinto JR, Hausen H. Classification of papillomaviruses. Virol- Mirandola RS, Benesi FJ, Birgel EH, Pereira CA, Beçak ogy 2004;324:17-27. W. Bovine papillomavirus transmission and chromo- 4. Howley PM, Lowy DR. Papillomaviruses. In: Knipe somal aberrations: an experimental model. J Gen DM, Howley PM, editors. Fields virology, 5th ed. Virol 1998;79:2127-35. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 2299-354. 138S TRANSFUSION Volume 49, August 2009 Supplement.
Load more

Recommended publications
  • Identification of Papillomaviruses in Butchers' Warts
    0022-202X/ 8 1/ 7602-0097$02.00/ 0 THE J OU RNAL OF INV ESTIGATIV E DERMATOLOGY, 76:97- 102 1981 Vol. 76, No.2 Copyright © !98 1 by The Williams & Wilkins Co. Printed in U.S. A. Identification of Papillomaviruses in Butchers' Warts GERARD ORTH, D.V.M., STEFANIA JABLONSKA, MD., MICHEL FAVRE, PH.D., 0DILE CROISSANT, PH.D., SLAVOMIR 0BALEK, M .D., MARIA JARZABEK-CHORZELSKA, PH.D., AND NICOLE JIBARD G. R . [NSERM U.J90. ln~>titut Pa~>t e ur, Paris, France (GO, MF, OC, NJ) and Department of Dermatology, Warww School of Medicine, Warsaw, Poland (SJ, SO, MJ-C). We have studied the papillomaviruses found in the butchers' warts, and to look for a possible correlation between hand warts of 60 butchers, most of them from 2 distant the types of viruses and the histological patterns of the lesions. slaughterhouses. Warts differing in morphology and lo­ MATERIALS AND METHODS cation were studied separately. The viruses were iden­ tified by molecular hybridization, restriction enzyme Subjects analysis and immunofluorescence. Four known human Our studies have been p erformed in 60 butchers whose work was papillomaviruses (HPV-1, HPV-2, HPV-3, HPV-4) were either to slaughter cattle, sheep and pigs, or to cut meat and viscera. detected and one hitherto unknown papillomavirus was Most of the butchers were from 2 slaughterhouses located in different identified in 9 butchers. The DNA of the latter virus did cities. All the warts were located on the hands: in 21 butchers, they the not anneal with any of the RNAs complementary to were dorsal and palmar; in 8, they were dorsal, palmar and around ey were dorsal on ly.
    [Show full text]
  • Diversity and Evolution of Viral Pathogen Community in Cave Nectar Bats (Eonycteris Spelaea)
    viruses Article Diversity and Evolution of Viral Pathogen Community in Cave Nectar Bats (Eonycteris spelaea) Ian H Mendenhall 1,* , Dolyce Low Hong Wen 1,2, Jayanthi Jayakumar 1, Vithiagaran Gunalan 3, Linfa Wang 1 , Sebastian Mauer-Stroh 3,4 , Yvonne C.F. Su 1 and Gavin J.D. Smith 1,5,6 1 Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore; [email protected] (D.L.H.W.); [email protected] (J.J.); [email protected] (L.W.); [email protected] (Y.C.F.S.) [email protected] (G.J.D.S.) 2 NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore 119077, Singapore 3 Bioinformatics Institute, Agency for Science, Technology and Research, Singapore 138671, Singapore; [email protected] (V.G.); [email protected] (S.M.-S.) 4 Department of Biological Sciences, National University of Singapore, Singapore 117558, Singapore 5 SingHealth Duke-NUS Global Health Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore 168753, Singapore 6 Duke Global Health Institute, Duke University, Durham, NC 27710, USA * Correspondence: [email protected] Received: 30 January 2019; Accepted: 7 March 2019; Published: 12 March 2019 Abstract: Bats are unique mammals, exhibit distinctive life history traits and have unique immunological approaches to suppression of viral diseases upon infection. High-throughput next-generation sequencing has been used in characterizing the virome of different bat species. The cave nectar bat, Eonycteris spelaea, has a broad geographical range across Southeast Asia, India and southern China, however, little is known about their involvement in virus transmission.
    [Show full text]
  • Is the ZIKV Congenital Syndrome and Microcephaly Due to Syndemism with Latent Virus Coinfection?
    viruses Review Is the ZIKV Congenital Syndrome and Microcephaly Due to Syndemism with Latent Virus Coinfection? Solène Grayo Institut Pasteur de Guinée, BP 4416 Conakry, Guinea; [email protected] or [email protected] Abstract: The emergence of the Zika virus (ZIKV) mirrors its evolutionary nature and, thus, its ability to grow in diversity or complexity (i.e., related to genome, host response, environment changes, tropism, and pathogenicity), leading to it recently joining the circle of closed congenital pathogens. The causal relation of ZIKV to microcephaly is still a much-debated issue. The identification of outbreak foci being in certain endemic urban areas characterized by a high-density population emphasizes that mixed infections might spearhead the recent appearance of a wide range of diseases that were initially attributed to ZIKV. Globally, such coinfections may have both positive and negative effects on viral replication, tropism, host response, and the viral genome. In other words, the possibility of coinfection may necessitate revisiting what is considered to be known regarding the pathogenesis and epidemiology of ZIKV diseases. ZIKV viral coinfections are already being reported with other arboviruses (e.g., chikungunya virus (CHIKV) and dengue virus (DENV)) as well as congenital pathogens (e.g., human immunodeficiency virus (HIV) and cytomegalovirus (HCMV)). However, descriptions of human latent viruses and their impacts on ZIKV disease outcomes in hosts are currently lacking. This review proposes to select some interesting human latent viruses (i.e., herpes simplex virus 2 (HSV-2), Epstein–Barr virus (EBV), human herpesvirus 6 (HHV-6), human parvovirus B19 (B19V), and human papillomavirus (HPV)), whose virological features and Citation: Grayo, S.
    [Show full text]
  • Bovine Papillomaviruses, Papillomas and Cancer in Cattle Giuseppe Borzacchiello, Franco Roperto
    Bovine papillomaviruses, papillomas and cancer in cattle Giuseppe Borzacchiello, Franco Roperto To cite this version: Giuseppe Borzacchiello, Franco Roperto. Bovine papillomaviruses, papillomas and cancer in cattle. Veterinary Research, BioMed Central, 2008, 39 (5), pp.1. 10.1051/vetres:2008022. hal-00902936 HAL Id: hal-00902936 https://hal.archives-ouvertes.fr/hal-00902936 Submitted on 1 Jan 2008 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Vet. Res. (2008) 39:45 www.vetres.org DOI: 10.1051/vetres:2008022 C INRA, EDP Sciences, 2008 Review article Bovine papillomaviruses, papillomas and cancer in cattle Giuseppe Borzacchiello*,FrancoRoperto Department of Pathology and Animal health, Faculty of Veterinary Medicine, Naples University “Federico II”, Via F. Delpino, 1 – 80137, Naples, Italy (Received 27 November 2007; accepted 7 May 2008) Abstract – Bovine papillomaviruses (BPV) are DNA oncogenic viruses inducing hyperplastic benign lesions of both cutaneous and mucosal epithelia in cattle. Ten (BPV 1-10) different viral genotypes have been characterised so far. BPV 1-10 are all strictly species-specific but BPV 1/2 may also infect equids inducing fibroblastic tumours. These benign lesions generally regress but may also occasionally persist, leading to a high risk of evolving into cancer, particularly in the presence of environmental carcinogenic co-factors.
    [Show full text]
  • Virus World As an Evolutionary Network of Viruses and Capsidless Selfish Elements
    Virus World as an Evolutionary Network of Viruses and Capsidless Selfish Elements Koonin, E. V., & Dolja, V. V. (2014). Virus World as an Evolutionary Network of Viruses and Capsidless Selfish Elements. Microbiology and Molecular Biology Reviews, 78(2), 278-303. doi:10.1128/MMBR.00049-13 10.1128/MMBR.00049-13 American Society for Microbiology Version of Record http://cdss.library.oregonstate.edu/sa-termsofuse Virus World as an Evolutionary Network of Viruses and Capsidless Selfish Elements Eugene V. Koonin,a Valerian V. Doljab National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, USAa; Department of Botany and Plant Pathology and Center for Genome Research and Biocomputing, Oregon State University, Corvallis, Oregon, USAb Downloaded from SUMMARY ..................................................................................................................................................278 INTRODUCTION ............................................................................................................................................278 PREVALENCE OF REPLICATION SYSTEM COMPONENTS COMPARED TO CAPSID PROTEINS AMONG VIRUS HALLMARK GENES.......................279 CLASSIFICATION OF VIRUSES BY REPLICATION-EXPRESSION STRATEGY: TYPICAL VIRUSES AND CAPSIDLESS FORMS ................................279 EVOLUTIONARY RELATIONSHIPS BETWEEN VIRUSES AND CAPSIDLESS VIRUS-LIKE GENETIC ELEMENTS ..............................................280 Capsidless Derivatives of Positive-Strand RNA Viruses....................................................................................................280
    [Show full text]
  • Chronic Viral Infections Vs. Our Immune System: Revisiting Our View of Viruses As Pathogens
    Chronic Viral Infections vs. Our Immune System: Revisiting our view of viruses as pathogens Tiffany A. Reese Assistant Professor Departments of Immunology and Microbiology Challenge your idea of classic viral infection and disease • Define the microbiome and the virome • Brief background on persistent viruses • Illustrate how viruses change disease susceptibility – mutualistic symbiosis – gene + virus = disease phenotype – virome in immune responses Bacteria-centric view of the microbiome The microbiome defined Definition of microbiome – Merriam-Webster 1 :a community of microorganisms (such as bacteria, fungi, and viruses) that inhabit a particular environment and especially the collection of microorganisms living in or on the human body 2 :the collective genomes of microorganisms inhabiting a particular environment and especially the human body Virome Ø Viral component of the microbiome Ø Includes both commensal and pathogenic viruses Ø Viruses that infect host cells Ø Virus-derived elements in host chromosomes Ø Viruses that infect other organisms in the body e.g. phage/bacteria Viruses are everywhere! • “intracellular parasites with nucleic acids that are capable of directing their own replication and are not cells” – Roossinck, Nature Reviews Microbiology 2011. • Viruses infect all living things. • We are constantly eating and breathing viruses from our environment • Only a small subset of viruses cause disease. • We even carry viral genomes as part of our own genetic material! Diverse viruses all over the body Adenoviridae Picornaviridae
    [Show full text]
  • Papillomavirus Virus-Like Particles As Vehicles for the Delivery of Epitopes Or Genes
    Arch Virol (2006) 151: 2133–2148 DOI 10.1007/s00705-006-0798-8 Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes Y.-F. Xu1, Y.-Q. Zhang2, X.-M. Xu1, and G.-X. Song1 1Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China 2Department of Physical Education, Zhejiang Water Conservancy and Hydropower College, Hangzhou, P.R. China Received November 16, 2005; accepted May 4, 2006 Published online June 22, 2006 c Springer-Verlag 2006 Summary. Papillomaviruses (PVs) are simple double-strand DNA viruses whose virion shells are T = 7 icosahedrons and composed of major capsid protein L1 and minor capsid protein L2. L1 alone or together with L2 can self-assemble into virus- like particles (VLPs) when expressed in eukaryotic or prokaryotic expression systems.Although the VLPs lack the virus genome DNA, their morphological and immunological characteristics are very similar to those of nature papillomaviruses. PVVLP vaccination can induce high titers of neutralizing antibodies and can effec- tively protect animals or humans from PV infection. Moreover, PVVLPs have been good candidates for vehicles to deliver epitopes or genes to target cells. They are widely used in the fields of vaccine development, neutralizing antibody detection, basic virologic research on papillomaviruses, and human papillomavirus (HPV) screening. Besides the structural biology and immunological basis for PV VLPs used as vehicles to deliver epitopes or genes, this review details the latest findings on chimeric papillomavirus VLPs and papillomavirus pseudoviruses, which are two important forms of PV VLPs used to transfer epitopes or genes.
    [Show full text]
  • Molecular Characterization and Developing a Point-Of-Need Molecular Test for Diagnosis of Bovine Papillomavirus (BPV) Type 1 in Cattle from Egypt
    animals Article Molecular Characterization and Developing a Point-of-Need Molecular Test for Diagnosis of Bovine Papillomavirus (BPV) Type 1 in Cattle from Egypt Mohamed El-Tholoth 1,2,3 , Michael G. Mauk 2, Yasser F. Elnaker 4 , Samah M. Mosad 1, Amin Tahoun 5, Mohamed W. El-Sherif 6, Maha S. Lokman 7,8 , Rami B. Kassab 8,9 , Ahmed Abdelsadik 10, Ayman A. Saleh 11 and Ehab Kotb Elmahallawy 12,13,* 1 Department of Virology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt; [email protected] (M.E.-T.); [email protected] (S.M.M.) 2 Department of Mechanical Engineering and Applied Mechanics, University of Pennsylvania, Philadelphia, PA 19104, USA; [email protected] 3 Health Sciences Division, Veterinary Sciences Program, Al Ain Men’s Campus, Higher Colleges of Technology, Al Ain 17155, UAE 4 Department of Animal Medicine (Infectious Diseases), Faculty of Veterinary Medicine, The New Valley University, El-Karga 72511, New Valley, Egypt; [email protected] 5 Department of Animal Medicine, Faculty of Veterinary Medicine, Kafrelshkh University, Kafrelsheikh 33511, Egypt; [email protected] 6 Department of Surgery, Anesthesiology and Radiology, Faculty of Veterinary Medicine, The New Valley University, El-Karga 72511, New Valley, Egypt; [email protected] 7 Biology Department, College of Science and Humanities, Prince Sattam bin Abdul Aziz University, Alkharj 11942, Saudi Arabia; [email protected] 8 Department of Zoology and Entomology, Faculty of Science, Helwan University, 11795 Cairo, Egypt;
    [Show full text]
  • (BAD) Guidelines for Management of Cutaneous Warts 2014
    BJD GUIDELINES British Journal of Dermatology British Association of Dermatologists’ guidelines for the management of cutaneous warts 2014 J.C. Sterling,1 S. Gibbs,2 S.S. Haque Hussain,1 M.F. Mohd Mustapa3 and S.E. Handfield-Jones4 1Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 OQQ, U.K. 2Great Western Hospital, Marlborough Road, Swindon SN3 6BB, U.K. 3British Association of Dermatologists, Willan House, 4 Fitzroy Square, London W1T 5HQ, U.K. 4West Suffolk Hospital, Hardwick Lane, Bury St Edmunds, Suffolk IP33 2QZ, U.K. 1.0 Purpose and scope Correspondence Jane Sterling. The overall objective of the guideline is to provide up-to-date, E-mail: [email protected] evidence-based recommendations for the management of infectious cutaneous warts caused by papillomavirus infection. Accepted for publication The document aims to (i) offer an appraisal of all relevant lit- 14 July 2014 erature since January 1999, focusing on any key develop- ments; (ii) address important practical clinical questions Funding sources relating to the primary guideline objective, i.e. accurate diag- None. nosis and identification of cases and suitable treatment; (iii) provide guideline recommendations, where appropriate with Conflicts of interest some health economic implications; and (iv) discuss potential J.C.S. has received travel and accommodation expenses from LEO Pharma (nonspe- developments and future directions. cific) and has been an invited speaker at educational events for Healthcare Education Services (nonspecific). The guideline is presented as a detailed review with high- lighted recommendations for practical use in the clinic, in J.C.S., S.G., S.S.H.H.
    [Show full text]
  • Packaging of Genomic RNA in Positive-Sense Single-Stranded RNA Viruses: a Complex Story
    viruses Review Packaging of Genomic RNA in Positive-Sense Single-Stranded RNA Viruses: A Complex Story Mauricio Comas-Garcia 1,2 1 Research Center for Health Sciences and Biomedicine (CICSaB), Universidad Autónoma de San Luis Potosí (UASLP), Av. Sierra Leona 550 Lomas 2da Seccion, 72810 San Luis Potosi, Mexico; [email protected] 2 Department of Sciences, Universidad Autónoma de San Luis Potosí (UASLP), Av. Chapultepec 1570, Privadas del Pedregal, 78295 San Luis Potosi, Mexico Received: 14 February 2019; Accepted: 8 March 2019; Published: 13 March 2019 Abstract: The packaging of genomic RNA in positive-sense single-stranded RNA viruses is a key part of the viral infectious cycle, yet this step is not fully understood. Unlike double-stranded DNA and RNA viruses, this process is coupled with nucleocapsid assembly. The specificity of RNA packaging depends on multiple factors: (i) one or more packaging signals, (ii) RNA replication, (iii) translation, (iv) viral factories, and (v) the physical properties of the RNA. The relative contribution of each of these factors to packaging specificity is different for every virus. In vitro and in vivo data show that there are different packaging mechanisms that control selective packaging of the genomic RNA during nucleocapsid assembly. The goals of this article are to explain some of the key experiments that support the contribution of these factors to packaging selectivity and to draw a general scenario that could help us move towards a better understanding of this step of the viral infectious cycle. Keywords: (+)ssRNA viruses; RNA packaging; virion assembly; packaging signals; RNA replication 1. Introduction Nucleocapsid assembly and the RNA replication of positive-sense single-stranded RNA [(+)ssRNA] viruses occur in the cytoplasm.
    [Show full text]
  • Primary Cultures Derived from Bovine Papillomavirus-Infected Lesions As
    Journal of Cancer Research and Therapeutic Oncology Research Open Access Primary Cultures Derived From Bovine Papillomavirus-Infected Lesions As Model To Study Metabolic Deregulation Rodrigo Pinheiro Araldi1,2, Paulo Luiz de Sá Júnior1, Roberta Fiusa Magnelli1,2, Diego Grando Módolo1, Jacqueline Mazzuchelli de Souza1, Diva Denelle Spadacci-Morena3, Rodrigo Franco de Carvalho1, Willy Beçak1, Rita de Cassia Stocco1,* 1Genetics Laboratory, Butantan Institute, Vital Brazil Avenue 1500, São Paulo-SP, Brazil 2Biotechnology Interunit Post-graduation Program IPT/Butantã/USP, University of São Paulo, Lineu Prestes 2415, São Paulo-SP, Brazil 3Physiopathology Laboratory, Butantan Institute, Vital Brazil 1500, São Paulo-SP, Brazil *Corresponding author: Rita de Cassia Stocco, Genetics Laboratory (Viral Oncogenesis), Butantan Institute, Vital Brazil St. 1500, São Paulo-SP, Brazil, Phone/Fax: 55 (11) 2627-9701; E-mail: [email protected] Received Date: November 10, 2016; Accepted Date: November 23, 2016; Published Date: November 25, 2016 Citation: Rodrigo Pinheiro Araldi, et al. (2016) Primary Cultures Derived From Bovine Papillomavirus-Infected Lesions As Model To Study Metabolic Deregulation. J Cancer Res Therap Oncol 4: 1-18 Abstract Bovine papillomavirus (BPV) is the etiological agent of bovine papillomatosis, disease characterized by the presence of mul- tiple papillomas that can regress or to progress to malignances. Due to the pathological similarities with the human papil- lomavirus (HPV), BPV is considered a prototype to study the papillomavirus-associated oncogenic process. Although it is clear that both BPV and HPV can interact with host chromatin, the interaction of these viruses with cell metabolism remains understudied due to the little attention given to primary cultures derived from papillomavirus-infected lesions.
    [Show full text]
  • Phylogenetic Factorization of Mammalian Viruses Complements Trait- Based Analyses and Guides Surveillance Efforts
    bioRxiv preprint doi: https://doi.org/10.1101/267252; this version posted February 19, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Phylogenetic factorization of mammalian viruses complements trait- based analyses and guides surveillance efforts Alex D. Washburne1*, Daniel E. Crowley1, Daniel J. Becker1,2, Kevin J. Olival3, Matthew Taylor1, Vincent J. Munster4, Raina K. Plowright1 1Department of Microbiology and Immunology, Montana State University, Bozeman MT 2Center for the Ecology of Infectious Disease, University of Georgia, Athens, GA 3EcoHealth Alliance New York, NY 4National Institute of Allergy and Infectious Diseases, Hamilton, MT *Corresponding author: [email protected] Abstract Predicting which novel microorganisms may spill over from animals to humans has become a major priority in infectious disease biology. However, there are few tools to help assess the zoonotic potential of the enormous number of potential pathogens, the majority of which are undiscovered or unclassified and may be unlikely to infect or cause disease in humans. We adapt a new biological machine learning technique - phylofactorization - to partition viruses into clades based on their non-human host range and whether or not there exist evidence they have infected humans. Our cladistic analyses identify clades of viruses with common within-clade patterns - unusually high or low propensity for spillover. Phylofactorization by spillover yields many clades of viruses containing few to no representatives that have spilled over to humans, including the families Papillomaviridae and Herpesviridae, and the genus Parvovirus.
    [Show full text]